Skip to main content
Log in

Levosimendan – kein Effekt auf das Multiorganversagen beim septischen Schock

Levosimendan—no effect on multiorgan failure in septic shock

  • Journal Club
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637

    Article  PubMed  Google Scholar 

  2. Gordon AC, Perkins GD, Singer M et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638–1648. doi:10.1056/nejmoa1609409

    Article  CAS  PubMed  Google Scholar 

  3. Hunter JD, Doddi M (2010) Sepsis and the heart. Br J Anaesth 104:3–11

    Article  CAS  PubMed  Google Scholar 

  4. Janssens U, Graf J (2008) Kardiovaskuläres Versagen in der Sepsis. Anasthesiol Intensivmed Notfallmed Schmerzther 43:56–63

    Article  PubMed  Google Scholar 

  5. Jardin F, Fourme T, Page B et al (1999) Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 116:1354–1359

    Article  CAS  PubMed  Google Scholar 

  6. Mebazaa A, Nieminen MS, Packer M et al (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297:1883–1891

    Article  CAS  PubMed  Google Scholar 

  7. Müller-Werdan U, Buerke M, Christoph A et al (2006) Septische Kardiomyopathie. Intensivmed Notfallmed 43:486–497

    Article  Google Scholar 

  8. Orme RM, Perkins GD, McAuley DF et al (2014) An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial. Trials 15:199

    Article  PubMed  PubMed Central  Google Scholar 

  9. Pierrakos C, Velissaris D, Franchi F et al (2014) Levosimendan in critical illness: a literature review. J Clin Med Res 6:75–85

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200

    Article  PubMed  Google Scholar 

  11. Riessen R, Tschritter O, Janssens U et al (2016) Katecholamine: Pro und Kontra. Med Klin Intensivmed Notfmed 111:37–46

    Article  CAS  PubMed  Google Scholar 

  12. Schlurmann CN, Reinohl J, Kalbhenn J (2016) Levosimendan im septischen Schock bei Tako-Tsubo-Kardiomyopathie. Anaesthesist 65:46–49

    Article  PubMed  Google Scholar 

  13. Schwinger RH, Brixius K (2005) Wenn die Myofilamente sensibel werden. Ca2+ Sensitizer zur Therapie der Herzinsuffizienz. Dtsch Med Wochenschr 130:969–973

    Article  CAS  PubMed  Google Scholar 

  14. Vincent JL, de Mendonca A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on „sepsis-related problems“ of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800

    Article  CAS  PubMed  Google Scholar 

  15. Wilson RF, Thal AP, Kindling PH et al (1965) Hemodynamic measurement in septic shock. Ann Surg 91:121–129

    Google Scholar 

  16. Zangrillo A, Putzu A, Monaco F et al (2015) Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials. J Crit Care 30:908–913

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. Janssens.

Ethics declarations

Interessenkonflikt

U. Janssens gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

S. Kluge, Hamburg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Janssens, U. Levosimendan – kein Effekt auf das Multiorganversagen beim septischen Schock. Med Klin Intensivmed Notfmed 112, 254–257 (2017). https://doi.org/10.1007/s00063-016-0248-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-016-0248-7

Navigation